EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitLeitlinieOpen Access

The CANMAT and ISBD Guidelines for the Treatment of Bipolar Disorder: Summary and a 2023 Update of Evidence

Kamyar Keramatian, Nellai K Chithra, Lakshmi N Yatham

Focus · 2023-10 · 21 (4) · 344-353

DOI: 10.1176/appi.focus.20230009 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Focus, 2023-10. Verfasst von Kamyar Keramatian und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada. Die Arbeit wurde bisher 83-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bipolar disorder is a complex and heterogeneous psychiatric condition that affects more than 2% of the population. The assessment and treatment of bipolar disorder can be a challenge for clinicians, given its clinical complexity and the rapidly changing treatment landscape with the growing range of treatment options that are becoming available for various phases of the illness. To help clinicians navigate the complexity involved in the assessment and management of bipolar disorder, the guidelines of the 2018 Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) synthesized the evidence on the efficacy, safety, and tolerability of treatments for bipolar disorder and translated it into first-, second-, and third-line treatment recommendations. The main objective of this contribution is to provide clinicians with a summary of the 2018 CANMAT/ISBD guideline recommendations with the addition of any new evidence for the treatment of bipolar disorder across the lifespan.

Schlagwörter

Stichwörter der Autor:innen

Bipolar DisorderClinical Drug StudiesEvidence-Based PracticePractice Guidelines

Autor:innen und Institutionen

  • Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada.

Zitieren

APA

Keramatian, K., Chithra, N. K., & Yatham, L. N. (2023). The CANMAT and ISBD Guidelines for the Treatment of Bipolar Disorder: Summary and a 2023 Update of Evidence. Focus, 21(4), 344-353. https://doi.org/10.1176/appi.focus.20230009

Vancouver

Keramatian K, Chithra NK, Yatham LN. The CANMAT and ISBD Guidelines for the Treatment of Bipolar Disorder: Summary and a 2023 Update of Evidence. Focus. 2023;21(4):344-353. doi:10.1176/appi.focus.20230009

BibTeX
@article{Keramatian2023,
  author = {Keramatian, Kamyar and Chithra, Nellai K and Yatham, Lakshmi N},
  title = {The CANMAT and ISBD Guidelines for the Treatment of Bipolar Disorder: Summary and a 2023 Update of Evidence},
  journal = {Focus},
  year = {2023},
  volume = {21},
  number = {4},
  pages = {344--353},
  doi = {10.1176/appi.focus.20230009}
}
Kostenlos starten →